Anduril Australia has delivered a UAS and intrusion detection system for a RAAF trial within 15 weeks from contract signing to implementation and training of the first cohort of users.
Anduril Australia is delivering the UAS and intrusion detection technology under a capability-as-a-service model, which the company describes as 'maintaining continuous hardware and software system updates and develops and deploying new technologies to evolve and adapt to the unique climate, topography and evolving operating environment.'
The RAAF is reportedly using Anduril's technologies and service to define future requirements for air base security capabilities and to develop new tactics and operating procedures for improved security outcomes. Since the trial commenced in October 2024, Anduril says it has delivered four hardware and sixteen software changes, through rolling upgrades, at no additional cost.
"Human-machine teaming is already in action at RAAF Base Darwin," the company said in a statement. "A number of new tactics and operating procedures using the UAS and intrusion detection technology have been used to improve monitoring and response to air and ground security threats."
"We are only six months into the RAAF contract but our UAS and intrusion detection technology has been performing well, delivering on its contractual commitments," David Goodrich, Executive Chairman and CEO Anduril Australia said.
"We continue to calibrate each of the sensors to react to the unique climatic environment, topography, flora and fauna. Our software and hardware team continues to evolve the system, with direct input from the RAAF, to optimise the performance for the unique needs of RAAF Base Darwin.
"It is very early days but already the results are impressive, and I am excited to see what else this partnership will bring."
"The three year trial will inform our future capability needs for UAS and intrusion detection technology through a learn-by-doing approach," a RAAF spokesperson said. "Anduril's capability-as-a-service model provides a versatile platform to focus on trial outcomes."